Back

Comparative validation of seven ESC/ERS-consistent risk stratification scores in a nationwide Pulmonary Arterial Hypertension Registry

30 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Risk assessment in pulmonary arterial hypertension Pulmonary Hypertension ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Panagiotis Simitsis

Attikon University Hospital, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
A modified 4-strata risk assessment incorporating TAPSE/sPAP for pulmonary arterial hypertension: evidence from a large chinese real-world cohort
Doctor S. Li (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Discordance between PAH risk scores in systemic sclerosis–associated pulmonary arterial hypertension
Doctor A. Cruz Utrilla (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Impact of cardiovascular comorbidity burden in pulmonary arterial hypertension: a propensity score-matched analysis
Doctor Q. Wang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Patient-reported physical activity improves risk stratification beyond COMPERA 2.0 in PAH and CTEPH
Mrs I. Silfversparre (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Age as an independent predictor of mortality in idiopathic and connective tissue disease-associated PAH: from the Spanish Registry of Pulmonary Hypertension (REHAP Registry)
Doctor A. Cruz Utrilla (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Risk assessment in pulmonary arterial hypertension

The Event

Event poster

ESC Congress 2026

30 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Enhancing risk stratification in pulmonary hypertension: integrating echocardiographic parameters with the REVEAL Lite 2.0 score
30 August 2025
thumbnail
Congress Presentation
Head-to-head comparison of CHADS₂, CHA₂DS₂-VASc, CHA₂DS₂-VA, HAS-BLED, and HELT-E₂S₂ scores in edoxaban treated atrial fibrillation patients: a 2-year analysis from the ETNA-AF Global program
28 August 2026
thumbnail
Congress Presentation
An external validation of prognostic scores for patients with severe tricuspid regurgitation
27 August 2023
thumbnail
Congress Presentation
Plasma E-selectin and C-C motif chemokine ligand 3 differentiate pulmonary arterial hypertension from other forms of pulmonary hypertension and healthy controls
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources